Susan Kelly

Chicago, United States

Reporter at MedTech Dive

Featured in: Favicon

medtechdive.com Favicon

healthcaredive.com Favicon

newsbreak.com Favicon

hrdive.com Favicon

supplychaindive.com Favicon

biopharmadive.com Favicon

cybersecuritydive.com Favicon

esgclarity.com Favicon

legaldive.com Favicon

yahoo.com (+1) + 4 more

Articles

Medtronic training pact includes Hugo robot, cardiac ablation tech

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Medtronic unveiled a collaboration Tuesday to integrate its technologies at IRCAD North America, a non-profit subsidiary of Atrium Health focused on surgical education, research and innovation. Founded in Strasbourg, France, in 1994, IRCAD now has centers around the world that offer hands-on training in minimally invasive surgery.
SS Innovations’ robot used in its first cardiac surgery in Americas

1 week ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Surgical robot developer SS Innovations International said Monday the first robotic cardiac surgery in the Americas using its SSi Mantra 3 system was performed at Interhospital in Guayaquil, Ecuador. The robotic atrial septal defect closure procedure repaired a hole between the upper two chambers of the patient’s heart.
J&J may take a softer tariff hit after US-China pause, CFO says

3 weeks ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Johnson & Johnson CFO Joseph Wolk, at the Bernstein investor conference last week, tempered the company's expectation that it would suffer a $400 million tariff impact this year. Wolk gave the update after the U.S. and China reached a temporary agreement to pause escalating tariff rates between the two countries for 90 days.
FDA declines to appeal court order that stopped LDT final rule

3 weeks ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. The Food and Drug Administration did not appeal a recent U.S. District Court decision that set aside the agency’s final rule aimed at increasing its authority over laboratory developed tests, according to two lab industry groups. The 60-day window for the FDA to appeal the ruling by the U.S. District Court for the Eastern District of Texas expired over the weekend.
Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Abbott said Tuesday it received Food and Drug Administration approval for the Tendyne transcatheter mitral valve replacement system to treat calcium buildup in the ring that supports the heart valve. The device is available for patients with severe mitral annular calcification who are not candidates for open heart surgery or transcatheter mitral valve repair.
Zimmer hires former Nevro CEO Kevin Thornal

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Name: Kevin ThornalNew title: Group president for global businesses and the Americas, Zimmer BiometPrevious title: President and CEO, NevroZimmer Biomet named Kevin Thornal to the newly created position of group president for global businesses and the Americas, effective July 1, the orthopedics device maker said Tuesday.
Cost cuts, production shifts: How medtech firms are managing tariffs

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Medical device makers are leaning on their global manufacturing footprints to shift production and inventory as they navigate fluid tariff policies. Large medtech manufacturers are avoiding potentially costly strategies such as reducing sales staff or investments in research and development, analysts said in interviews with MedTech Dive. Price increases are a last resort.
EndoQuest, Virtuoso begin clinical trials for surgical robots

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. EndoQuest Robotics, developer of an endoluminal robotic surgery system, said Thursday that the first procedures in its pivotal trial were completed at HCA Houston Healthcare Medical Center. The technology is designed to navigate through natural body openings. EndoQuest received an investigational device exemption from the Food and Drug Administration in December to study its system in procedures to remove colorectal lesions.
AdvaMed CEO Scott Whitaker pleads for tariff relief in Senate hearing

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. AdvaMed CEO Scott Whitaker told a Senate panel Wednesday that tariffs threaten the U.S. medtech industry’s role as the “global superpower” of medical innovation and called for greater flexibility to protect its complex supply chain.
Vicarious Surgical, UMass partner; SS Innovations targets de novo submission

1 month ago | medtechdive.com | Susan Kelly

This audio is auto-generated. Please let us know if you have feedback. Vicarious Surgical signed an agreement with UMass Memorial Medical Center, the UMass Memorial Health system’s flagship hospital, to promote adoption of its robotic surgery system. Vicarious expects to begin treating its first clinical patients this year and submit a request for de novo classification to the Food and Drug Administration in late 2026.